Adimmune Corp (國光生技) on Thursday said it is developing a COVID-19 vaccine in cooperation with the National Health Research Institutes, and plans to run animal tests in the second quarter if its research proceeds smoothly.
The Taichung-based firm has been working to develop the vaccine utilizing its recombinant protein technology since acquiring a genetic sequence from the US Centers for Disease Control last month, Adimmune spokesman Pan Fei (潘飛) told the Taipei Times by telephone.
As the virus’ sequence reportedly evolves and appears different in separate regions, the company is attempting to determine whether the difference is considerable enough to affect the efficacy of a vaccine, Pan said.
“Though the novel coronavirus’ genetic sequence is 70 percent similar to that of the SARS virus, it is still not easy to make the vaccine,” he said.
Earlier this month National Taiwan University managed to isolate the virus strain of COVID-19, and Medigen Vaccine Biologics Corp (高端疫苗) on Monday said that it expects to conduct clinical tests for its vaccine in the second half of this year.
Adimmune would not use the isolated virus strain during its development to protect the safety of its research team, Pan said, adding that it is hard to forecast when it would enter the human trial stage
The Central Epidemic Command Center on Thursday said that an infected Taiwanese businessman returning from Zhejiang Province in China last month had antibodies against the virus in his blood.
However, Adimmune said that those antibodies would not help in the development of vaccines.
“Antibodies are created by patients’ immune systems. However, our goal is to produce an antigen against the virus, which is different,” Pan said.
Huawei Technologies Co (華為) largely omitted mention of its controversial Mate 60 smartphone series at a grand showcase of its new consumer products yesterday. The Shenzhen-based company would increase smartphone production in response to demand, said consumer division chief Richard Yu (余承東), without naming the handset triggering that surge. The Mate 60 Pro earned international notoriety with its advanced made-in-China processor last month, causing concern in Washington about Huawei’s progress toward developing in-house chipmaking capabilities despite US trade curbs. Huawei’s new phones have fired up the company’s sales and were among the top sellers in China in the week before Apple Inc’s
SLUMP: The electronics, machinery and traditional industries posted the largest decline in the past year; overall, sectors showed gains over the previous month Taiwan’s industrial production index decreased 10.53 percent year-on-year to 91.38 last month, falling for a 15th consecutive month on an annual basis, as weak global economic growth continued to weigh on end-market demand and investment momentum, the Ministry of Economic Affairs said on Saturday. The industrial production index gauges output in Taiwan’s four main industries: manufacturing, electricity and gas supply, water supply, and mining and quarrying. Last month’s decline was the smallest contraction since March when the index dropped 16.03 percent from a year earlier. On a monthly basis, the index rose 7.28 percent, marking a second straight month of improvement,
US-based tech giant Google said yesterday that its efforts to build four underseas cables to connect Taiwan with the world had created more than 64,000 jobs and generated about US$26 billion in GDP for Taiwan as of 2021. The US company has transformed Taiwan into a strategic cloud infrastructure hub in the world. The four undersea cables are part of the company’s investments in cloud infrastructure in Taiwan, and on the back of the undersea cables, a data center and a Google Cloud Region, which is a geographic area in which Google provides infrastructure and services for deploying applications, Google said in
Micron Technology Inc on Wednesday predicted a steeper loss than anticipated in the current quarter, indicating that an industry slump is still weighing on the largest US maker of memory chips. The company projected a fiscal first-quarter loss of as much as US$1.14 a share, excluding some items. Analysts had estimated a US$0.96 loss. On the bright side, revenue is expected to start recovering in the period. Micron predicted sales of US$4.2 billion to US$4.6 billion, compared with an estimate of US$4.21 billion. For Micron and competitors Samsung Electronics Co and SK Hynix Inc, this year has been brutal. Customers in their